We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including comple... read more Featured Products: More products

Download Mobile App




Multiplex Molecular Assay Identifies Major Vaginal Lactobacilli

By LabMedica International staff writers
Posted on 26 Mar 2014
Lactobacilli play a key role in promoting vaginal health and depletion of these bacteria is associated with bacterial vaginosis (BV), the most common vaginal disorder.

A novel single-tube multiplex quantitative polymerase chain reaction (qPCR) assay for the identification and quantitative assessment of the four major vaginal Lactobacillus species has been developed. More...


Microbiologists at the Femeris Women's Health Research Center (Hamilton, NJ, USA) assessed 60 vaginal swab specimens as part of a study on BV pathogenesis. Samples were shipped frozen in Universal Transport Medium (UTM-RT) (Copan Italia SpA; Brescia, Italy) from August to October of 2012.

DNA from clinical samples was extracted using the QIAamp Mini Kit (Qiagen; Valencia, CA, USA) in combination with pretreatment with proteinase K and mechanical homogenization. Multiplex and uniplex TaqMan qPCRs were performed using primers and probes from Integrated DNA Technologies (Coralville, IA, USA) and Qiagen’s RotorGene Q instruments were used for all qPCR assays.

The assay utility was evaluated by the analysis of lactobacilli in noncultured clinical vaginal swab specimens collected from BV patients and healthy individuals. As confirmed by the assay, L. crispatus, L. jensenii, and to a lesser extent L. gasseri, are common in the vagina of healthy women, whereas L. iners dominance is associated with BV. In order to confirm multiplex TaqMan qPCR results, bacterial cultures were isolated from vaginal samples and 11 swab specimens yielded isolates of Lactobacillus species identified in them by the multiplex TaqMan qPCR assay. A total of 11 individual Lactobacillus strains were obtained: three L. crispatus, two L. gasseri, two L. jensenii, and four L. iners. Their species assignments were confirmed by both multiplex TaqMan qPCR and uniplex SYBR Green qPCRs with 100% concordance.

The authors concludes that their assay had been validated using bacterial cultures of lactobacilli and other microbial commensal and pathogenic species populating the microflora of the lower female genital tract, human chromosomal DNA, synthetic plasmid controls, and clinical vaginal swab specimens. The multiplex qPCR assay is an advance in the detection and quantitation of the major vaginal lactobacilli, potentially facilitating the molecular diagnosis of BV and post-therapy restoration of the vaginal microflora. The study was published online on January 18, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Femeris Women's Health Research Center
Copan Italia 
Qiagen


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.